Issue 5, 2024

Disposable paper-based screen-printed electrochemical immunoplatform for dual detection of esophageal cancer biomarkers in patients' serum samples

Abstract

Esophageal cancer is an aggressive disease with an extremely poor prognosis. However, early detection and timely treatment improve the chances of survival. Therefore, in this study, disposable, low-cost, flexible, reagentless, and highly sensitive paper-based screen-printed electrochemical immunosensors were developed for the dual determination of cytokeratin fragment 21-1 (CYFRA-21-1) and tumor protein (TP53) biomarkers in patient serum samples. For this, graphite ink was prepared with the help of a screen-printing machine, a in homepaper-based screen-printed electrode (SPE) substrate was fabricated on its surface. The immobilization of antibodies (CYFRA21-1 and TP53, individually) and BSA were done on inhome paper-based SPE directly using the drop-cast method. The paper-based SPE and other immunoelectrodes were characterized using Fourier transform infrared (FT-IR) spectroscopy, contact angle, scanning electron microscopy (SEM), and energy dispersive X-ray (EDX) spectroscopy. Cyclic voltammetry (CV) and differential pulse voltammetry (DPV) were employed as electrochemical methods for evaluating the performances of immunoplatforms. Under the optimized conditions, the immunoplatforms exhibited a wide linear range for CYFRA21-1 and TP53 from 0.1 to 25 ng mL−1 and 0.001–10 ng mL−1, respectively. Comparatively, TP53 showed better results in terms of sensitivity [222.62 μA (log10 ng mL−1 cm−2)−1], the limit of quantification (LOQ) [0.018 ng mL−1], and the limit of detection (LOD) [0.005 ng mL−1] in contrast to CYFRA21-1 (sensitivity, 167.07 μA (log10 ng mL−1 cm−2)−1; LOQ, 0.041 ng mL−1; and LOD, 0.012 ng mL−1). Thus, the developed immunosensors could potentially be applied as biodevices in clinical laboratories or employed for detecting cancer biomarkers in different human fluids since this method is sensitive, uncomplicated, affordable, portable, and straightforward to develop.

Graphical abstract: Disposable paper-based screen-printed electrochemical immunoplatform for dual detection of esophageal cancer biomarkers in patients' serum samples

Supplementary files

Article information

Article type
Paper
Submitted
20 jul 2023
Accepted
14 dec 2023
First published
30 jan 2024
This article is Open Access
Creative Commons BY license

Mater. Adv., 2024,5, 2153-2168

Disposable paper-based screen-printed electrochemical immunoplatform for dual detection of esophageal cancer biomarkers in patients' serum samples

D. Verma, N. Dubey, A. K. Yadav, A. Saraya, R. Sharma and P. R. Solanki, Mater. Adv., 2024, 5, 2153 DOI: 10.1039/D3MA00438D

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements